[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 3036 Reported in Senate (RS)]

                                                       Calendar No. 675
111th CONGRESS
  2d Session
                                S. 3036

      To establish the Office of the National Alzheimer's Project.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           February 24, 2010

   Mr. Bayh (for himself, Ms. Collins, Mr. LeMieux, Mr. Tester, Mr. 
Whitehouse, Ms. Landrieu, Mr. Feingold, Ms. Stabenow, Mr. Conrad, Mrs. 
McCaskill, Mr. Chambliss, Mr. Schumer, Mrs. Gillibrand, Mr. Lieberman, 
 Mr. Johnson, Mr. Menendez, Mr. Gregg, Mr. Lautenberg, Mr. Warner, Mr. 
Carper, Mr. Bennet, Mr. Casey, Ms. Cantwell, Mr. Akaka, Mr. Cardin, Mr. 
Kohl, Mrs. Shaheen, Mr. Dodd, Mrs. Lincoln, Mrs. Boxer, Ms. Snowe, Mr. 
Kaufman, Mr. Inouye, and Mr. Burr) introduced the following bill; which 
  was read twice and referred to the Committee on Health, Education, 
                          Labor, and Pensions

                            December 6, 2010

Reported by Mr. Harkin, with an amendment and an amendment to the title
 [Strike out all after the enacting clause and insert the part printed 
                               in italic]

_______________________________________________________________________

                                 A BILL


 
      To establish the Office of the National Alzheimer's Project.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

<DELETED>SECTION 1. SHORT TITLE.</DELETED>

<DELETED>    This Act may be cited as the ``National Alzheimer's 
Project Act''.</DELETED>

<DELETED>SEC. 2. OFFICE OF THE NATIONAL ALZHEIMER'S PROJECT.</DELETED>

<DELETED>    (a) Establishment of Office.--There is established in the 
Office of the Secretary of Health and Human Services the Office of the 
National Alzheimer's Project (referred to in this Act as the 
``Office'').</DELETED>
<DELETED>    (b) Purpose of the Office.--The Office shall--</DELETED>
        <DELETED>    (1) accelerate the development of treatments that 
        would prevent, halt, or reverse the course of 
        Alzheimer's;</DELETED>
        <DELETED>    (2) be responsible for the creation and 
        maintenance of an integrated national plan to overcome 
        Alzheimer's;</DELETED>
        <DELETED>    (3) help to coordinate the health care and 
        treatment of citizens with Alzheimer's;</DELETED>
        <DELETED>    (4) ensure the inclusion of ethnic and racial 
        populations at higher risk for Alzheimer's or least likely to 
        receive care, in clinical, research, and service efforts with 
        the purpose of decreasing health disparities in 
        Alzheimer's;</DELETED>
        <DELETED>    (5) coordinate with international bodies to 
        integrate and inform the fight against Alzheimer's globally; 
        and</DELETED>
        <DELETED>    (6) provide information and coordination of 
        Alzheimer's research and services across all Federal 
        agencies.</DELETED>
<DELETED>    (c) Director of the Office.--</DELETED>
        <DELETED>    (1) Appointment.--The President shall appoint a 
        Director of the Office.</DELETED>
        <DELETED>    (2) Duties of the director.--</DELETED>
                <DELETED>    (A) In general.--The Director of the 
                Office shall--</DELETED>
                        <DELETED>    (i) oversee the creation and 
                        updating of the national plan described in 
                        subparagraph (B);</DELETED>
                        <DELETED>    (ii) use discretionary authority 
                        to evaluate all Federal programs around 
                        Alzheimer's, including budget requests and 
                        approvals; and</DELETED>
                        <DELETED>    (iii) prepare and submit to the 
                        President the annual budget estimate for the 
                        Office.</DELETED>
                <DELETED>    (B) National plan.--The Director of the 
                Office shall carry out an annual assessment of the 
                Nation's progress in preparing for the escalating 
                burden of Alzheimer's, including both implementation 
                steps and recommendations for priority actions based on 
                the assessment.</DELETED>
        <DELETED>    (3) Service by director.--The Director of the 
        Office shall serve on the advisory board of the Office of 
        Science and Technology to promote research efforts into 
        mechanisms to slow and stop the development of Alzheimer's for 
        those at risk of developing the disease.</DELETED>
<DELETED>    (d) Advisory Council.--</DELETED>
        <DELETED>    (1) In general.--There is established in the 
        Office an Advisory Council on Alzheimer's Research and 
        Treatment (referred to in this Act as the ``Advisory 
        Council'').</DELETED>
        <DELETED>    (2) Membership.--</DELETED>
                <DELETED>    (A) Federal members.--The Advisory Council 
                shall be comprised of the following experts:</DELETED>
                        <DELETED>    (i) A designee of the Centers for 
                        Disease Control and Prevention.</DELETED>
                        <DELETED>    (ii) A designee of the 
                        Administration on Aging.</DELETED>
                        <DELETED>    (iii) A designee of the Centers 
                        for Medicare & Medicaid Services.</DELETED>
                        <DELETED>    (iv) A designee of the Indian 
                        Health Service.</DELETED>
                        <DELETED>    (v) A designee of the Office of 
                        the Director of the National Institutes of 
                        Health.</DELETED>
                        <DELETED>    (vi) The Surgeon 
                        General.</DELETED>
                        <DELETED>    (vii) A designee of the National 
                        Science Foundation.</DELETED>
                        <DELETED>    (viii) A designee of the 
                        Department of Veterans Affairs.</DELETED>
                <DELETED>    (B) Non-federal members.--In addition to 
                the members outlined in subparagraph (A), the Advisory 
                Council shall include 12 expert members from outside 
                the Federal Government, which shall include--</DELETED>
                        <DELETED>    (i) 2 Alzheimer patient 
                        advocates;</DELETED>
                        <DELETED>    (ii) 2 Alzheimer 
                        caregivers;</DELETED>
                        <DELETED>    (iii) 2 health care 
                        providers;</DELETED>
                        <DELETED>    (iv) 2 representatives of State 
                        health departments;</DELETED>
                        <DELETED>    (v) 2 researchers with Alzheimer-
                        related expertise in basic, translational, 
                        clinical, or drug development science; 
                        and</DELETED>
                        <DELETED>    (vi) 2 voluntary health 
                        association representatives, including a 
                        national Alzheimer's disease organization that 
                        funds research and has demonstrated experience 
                        in care and patient services, and a State-based 
                        advocacy organization that provides services to 
                        families and professionals, including 
                        information and referral, support groups, care 
                        consultation, education, and safety 
                        services.</DELETED>
        <DELETED>    (3) Meetings.--The Advisory Council shall meet 
        quarterly and such meetings shall be open to the 
        public.</DELETED>
        <DELETED>    (4) Advice.--The Advisory Council shall advise the 
        Director of the Office.</DELETED>
        <DELETED>    (5) Annual report.--The Advisory Council shall 
        provide to the Director of the Office--</DELETED>
                <DELETED>    (A) recommendations for information to be 
                included in the annual report to Congress by the 
                Office; and</DELETED>
                <DELETED>    (B) an annually updated national 
                plan.</DELETED>
<DELETED>    (e) Annual Report.--The Director of the Office shall 
submit to Congress--</DELETED>
        <DELETED>    (1) an annual report that includes an evaluation 
        of all nationally and federally funded efforts in Alzheimer's 
        research, clinical care, institutional, and home- and 
        community-based programs and their outcomes; and</DELETED>
        <DELETED>    (2) an annually updated national plan.</DELETED>
<DELETED>    (f) Sunset.--The Office shall expire on December 31, 
2025.</DELETED>

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``National Alzheimer's Project Act''.

SEC. 2. THE NATIONAL ALZHEIMER'S PROJECT.

    (a) Definition of Alzheimer's.--In this Act, the term 
``Alzheimer's'' means Alzheimer's disease and related dementias.
    (b) Establishment.--There is established in the Office of the 
Secretary of Health and Human Services the National Alzheimer's Project 
(referred to in this Act as the ``Project'').
    (c) Purpose of the Project.--The Secretary of Health and Human 
Services, or the Secretary's designee, shall--
            (1) be responsible for the creation and maintenance of an 
        integrated national plan to overcome Alzheimer's;
            (2) provide information and coordination of Alzheimer's 
        research and services across all Federal agencies;
            (3) accelerate the development of treatments that would 
        prevent, halt, or reverse the course of Alzheimer's;
            (4) improve the--
                    (A) early diagnosis of Alzheimer's disease; and
                    (B) coordination of the care and treatment of 
                citizens with Alzheimer's;
            (5) ensure the inclusion of ethnic and racial populations 
        at higher risk for Alzheimer's or least likely to receive care, 
        in clinical, research, and service efforts with the purpose of 
        decreasing health disparities in Alzheimer's; and
            (6) coordinate with international bodies to integrate and 
        inform the fight against Alzheimer's globally.
    (d) Duties of the Secretary.--
            (1) In general.--The Secretary of Health and Human 
        Services, or the Secretary's designee, shall--
                    (A) oversee the creation and updating of the 
                national plan described in paragraph (2); and
                    (B) use discretionary authority to evaluate all 
                Federal programs around Alzheimer's, including budget 
                requests and approvals.
            (2) National plan.--The Secretary of Health and Human 
        Services, or the Secretary's designee, shall carry out an 
        annual assessment of the Nation's progress in preparing for the 
        escalating burden of Alzheimer's, including both implementation 
        steps and recommendations for priority actions based on the 
        assessment.
    (e) Advisory Council.--
            (1) In general.--There is established an Advisory Council 
        on Alzheimer's Research, Care, and Services (referred to in 
        this Act as the ``Advisory Council'').
            (2) Membership.--
                    (A) Federal members.--The Advisory Council shall be 
                comprised of the following experts:
                            (i) A designee of the Centers for Disease 
                        Control and Prevention.
                            (ii) A designee of the Administration on 
                        Aging.
                            (iii) A designee of the Centers for 
                        Medicare & Medicaid Services.
                            (iv) A designee of the Indian Health 
                        Service.
                            (v) A designee of the Office of the 
                        Director of the National Institutes of Health.
                            (vi) The Surgeon General.
                            (vii) A designee of the National Science 
                        Foundation.
                            (viii) A designee of the Department of 
                        Veterans Affairs.
                            (ix) A designee of the Food and Drug 
                        Administration.
                            (x) A designee of the Agency for Healthcare 
                        Research and Quality.
                    (B) Non-federal members.--In addition to the 
                members outlined in subparagraph (A), the Advisory 
                Council shall include 12 expert members from outside 
                the Federal Government, which shall include--
                            (i) 2 Alzheimer's patient advocates;
                            (ii) 2 Alzheimer's caregivers;
                            (iii) 2 health care providers;
                            (iv) 2 representatives of State health 
                        departments;
                            (v) 2 researchers with Alzheimer's-related 
                        expertise in basic, translational, clinical, or 
                        drug development science; and
                            (vi) 2 voluntary health association 
                        representatives, including a national 
                        Alzheimer's disease organization that has 
                        demonstrated experience in research, care, and 
                        patient services, and a State-based advocacy 
                        organization that provides services to families 
                        and professionals, including information and 
                        referral, support groups, care consultation, 
                        education, and safety services.
            (3) Meetings.--The Advisory Council shall meet quarterly 
        and such meetings shall be open to the public.
            (4) Advice.--The Advisory Council shall advise the 
        Secretary of Health and Human Services, or the Secretary's 
        designee.
            (5) Annual report.--The Advisory Council shall provide to 
        the Secretary of Health and Human Services, or the Secretary's 
        designee and Congress--
                    (A) an initial evaluation of all federally funded 
                efforts in Alzheimer's research, clinical care, and 
                institutional-, home-, and community-based programs and 
                their outcomes;
                    (B) initial recommendations for priority actions to 
                expand, eliminate, coordinate, or condense programs 
                based on the program's performance, mission, and 
                purpose;
                    (C) initial recommendations to--
                            (i) reduce the financial impact of 
                        Alzheimer's on--
                                    (I) Medicare and other federally 
                                funded programs; and
                                    (II) families living with 
                                Alzheimer's disease; and
                            (ii) improve health outcomes; and
                    (D) annually thereafter, an evaluation of the 
                implementation, including outcomes, of the 
                recommendations, including priorities if necessary, 
                through an updated national plan under subsection 
                (d)(2).
            (6) Termination.--The Advisory Council shall terminate on 
        December 31, 2025.
    (f) Data Sharing.--Agencies both within the Department of Health 
and Human Services and outside of the Department that have data 
relating to Alzheimer's shall share such data with the Secretary of 
Health and Human Services, or the Secretary's designee, to enable the 
Secretary, or the Secretary's designee, to complete the report 
described in subsection (g).
    (g) Annual Report.--The Secretary of Health and Human Services, or 
the Secretary's designee, shall submit to Congress--
            (1) an annual report that includes an evaluation of all 
        federally funded efforts in Alzheimer's research, clinical 
        care, and institutional-, home-, and community-based programs 
        and their outcomes;
            (2) an evaluation of all federally funded programs based on 
        program performance, mission, and purpose related to 
        Alzheimer's disease;
            (3) recommendations for--
                    (A) priority actions based on the evaluation 
                conducted by the Secretary and the Advisory Council 
                to--
                            (i) reduce the financial impact of 
                        Alzheimer's on--
                                    (I) Medicare and other federally 
                                funded programs; and
                                    (II) families living with 
                                Alzheimer's disease; and
                            (ii) improve health outcomes;
                    (B) implementation steps; and
                    (C) priority actions to improve the prevention, 
                diagnosis, treatment, care, institutional-, home-, and 
                community-based programs of Alzheimer's disease for 
                individuals with Alzheimer's disease and their 
                caregivers; and
            (4) an annually updated national plan.
    (h) Sunset.--The Project shall expire on December 31, 2025.
            Amend the title so as to read: ``A bill to establish the 
        National Alzheimer's Project.''.
                                                       Calendar No. 675

111th CONGRESS

  2d Session

                                S. 3036

_______________________________________________________________________

                                 A BILL

      To establish the Office of the National Alzheimer's Project.

_______________________________________________________________________

                            December 6, 2010

        Reported with an amendment and an amendment to the title